PCSA - Financial Reports List - Processa Pharmaceuticals, Inc. - IntrinsicAlpha

Processa Pharmaceuticals, Inc. PCSA

Healthcare - Biotechnology - NASDAQ - US

$ 0.2479

-5 %

$ 2.95 M

Market Cap

-0.08

P/E

FINANCIAL REPORTS

Reports

Report			Date	Revenue YoY	Net Income YoY	Operating Income YoY	View
Quarterly Report	Q1	8-K	2025-03-31	0.00%	-3.96%	100.00%
Quarterly Report	Q4	8-K	2024-12-31	0.00%	-13.46%	-10.74%
Annual Report	FY	10-K	2024-12-31	0.00%	-6.55%	-5.19%
Quarterly Report	Q3	8-K	2024-09-30	0.00%	-62.57%	-58.00%
Quarterly Report	Q2	8-K	2024-06-30	0.00%	-15.22%	-13.54%
Quarterly Report	Q1	8-K	2024-03-31	0.00%	-1633.31%	-36.87%
Quarterly Report	Q4	8-K	2023-12-31	0.00%	93.01%	-168.17%
Annual Report	FY	10-K	2023-12-31	0.00%	79.72%	58.38%
Quarterly Report	Q3	8-K	2023-09-30	0.00%	65.21%	64.21%
Quarterly Report	Q2	8-K	2023-06-30	0.00%	49.41%	47.51%

1